Role of gold and silver nanoparticles in cancer nano-medicine
- 13 March 2018
- journal article
- research article
- Published by Taylor & Francis Ltd in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup1), 1210-1220
- https://doi.org/10.1080/21691401.2018.1449118
Abstract
Development of nanoparticles (NPs) as a part of cancer therapeutics has given rise to a new field of research – cancer nanomedicine. In comparison to traditional anti-cancer drugs, NPs provide a targeted approach which prevents undesirable effects. In this communication, we have reviewed the role of gold and silver NPs (AgNPs) in the cancer nanomedicine. The preparation of gold NPs (AuNPs) and AgNPs can be grouped into three categories – physical, chemical and biological. Among the three approaches, the biological approach is growing and receiving more attention due to its safe and effective production. In this review, we have discussed important methods for synthesis of gold and AgNPs followed by techniques employed in characterization of their physicochemical properties, such as UV–visible spectroscopy, electron microscopy (TEM and SEM) and size and surface analysis (DLS). The mechanism of formation of these NPs in an aqueous medium through various stages – reduction, nucleation and growth has also been reviewed briefly. Finally, we conclude our review with the application of these NPs as anti-cancer agents and numerous mechanisms by which they render cancer cell toxicity.Keywords
Funding Information
- Council of Scientific and Industrial Research
- University of Delhi
This publication has 99 references indexed in Scilit:
- The fascinating world of nanoparticle researchMaterials Today, 2013
- Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer CellsBioMed Research International, 2013
- Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cellsActa Biomaterialia, 2011
- Inorganic Nanoparticles in Cancer TherapyPharmaceutical Research, 2010
- Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549Archives of Toxicology, 2010
- Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of OxaliplatinJournal of the American Chemical Society, 2010
- Anti-proliferative activity of silver nanoparticlesBMC Cell Biology, 2009
- Unique Cellular Interaction of Silver Nanoparticles: Size-Dependent Generation of Reactive Oxygen SpeciesThe Journal of Physical Chemistry B, 2008
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Laser ablation method: use of surfactants to form the dispersed Ag nanoparticlesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2002